Schizophrenia Trial, Recruiting NCT06650943 Sponsor: Hospital de Basurto Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06650943
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to an Early Intervention Program (EIP) for psychosis.
  • People who have experienced their first episode of psychosis within the last 5 years.
  • People who have a diagnosis of a psychotic disorder or a mood disorder with psychotic symptoms, as classified under the ICD-10 diagnostic system (confirm with trial site).

Who may not be able to join:

  • People whose thinking or learning difficulties, or an intellectual disability, would make it hard to take part in the study procedures.
  • People who also have a diagnosed neurological condition (a condition affecting the brain or nervous system).
  • People who have difficulty with language or understanding that would prevent accurate information from being collected during the study.
  • People who are taking or have taken medication to lower blood sugar levels (such as diabetes medication) before or during the study.
  • People who do not wish to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 646179740

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital de Basurto
Registry
ClinicalTrials.gov
Start date
25 October 2023
Est. completion
30 June 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov